An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis

Acta Neuropathologica

Volumn 107, Issue 5, 2004, Pages 381-388

  Blümcke, Ingmar ^a   Luyken, Cordelia ^b,d   Urbach, Horst ^b   Schramm, Johannes ^b   Wiestler, Otmar D ^b,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Brain; Glioma; Seizure; Tumor

Indexed keywords

CD34 ANTIGEN; MICROTUBULE ASSOCIATED PROTEIN 2; PROTEIN P53;

ADULT; ANAMNESIS; ARTICLE; ASTROCYTOMA; BENIGN TUMOR; CANCER GRADING; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICAL DYSPLASIA; CYTOPATHOLOGY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EPILEPSY; EPITHELIUM TUMOR; FOLLOW UP; GLIOMA; GLIOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACTABLE EPILEPSY; MALIGNANT TRANSFORMATION; MITOSIS; NEUROPATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SURVIVAL TIME; TERATOMA; TUMOR CLASSIFICATION; TUMOR GROWTH; TUMOR RECURRENCE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; COHORT STUDIES; EPILEPSY; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; STAINING AND LABELING; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 2342438450     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-004-0833-3     Document Type: Article

References (21)

1. Blümcke I, Wiestler OD (2002) Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol 61:575-584
2. Blümcke I, Giencke K, Wardelmann E, Beyenburg S, Kral T, Sarioglu N, Pietsch T, Wolf HK, Schramm J, Elger CE, Wiestler OD (1999) The CD34 epitope is expressed in neoplastic and malformative lesions associated with chronic, focal epilepsies. Acta Neuropathol 97:481-490
3. Blümcke I, Becker AJ, Normann S, Hans V, Riederer BM, Krajewski S, Wiestler OD, Reifenberger G (2001) Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells. J Neuropathol Exp Neurol 60:984-993
4. Cosenza MA, Zhao ML, Shankar SL, Shafit-Zagardo B, Lee SC (2002) Up-regulation of MAP2e-expressing oligodendrocytes in the white matter of patients with HIV-1 encephalitis. Neuropathol Appl Neurobiol 28:480-488
5. Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER, Vedrenne C (1988) Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 23:545-556
6. Forsyth PA, Shaw EG, Scheithauer BW, O'Fallon JR, Layton DD Jr, Katzmann JA (1993) Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients. Cancer 72:1335-1342
7. Fried I, Kim JH, Spencer DD (1994) Limbic and neocortical gliomas associated with intractable seizures: a distinct clinicopathological group. Neurosurgery 34:815-823
8. Goldring S, Rich KM, Picker S (1986) Experience with gliomas in patients presenting with a chronic seizure disorder. Clin Neurosurg 33:15-42
9. Haddad SF, Moore SA, Menezes AH, VanGilder JC (1992) Ganglioglioma: 13 years of experience. Neurosurgery 31:171-178
10. Kirkpatrick PJ, Honavar M, Janota I, Polkey CE (1993) Control of temporal lobe epilepsy following en bloc resection of low-grade tumors. J Neurosurg 78:19-25
11. Kleihues P, Cavenee WK (2000): Pathology and genetics of tumours of the nervous system World Health Organization Classification of Tumours. IARC, Lyon
12. Kral T, Clusmann H, Urbach H, Schramm J, Elger CE, Kurthen M, Grunwald T (2002) Preoperative evaluation for epilepsy surgery (Bonn algorithm). Zentralbl Neurochir 63:101-105
13. Luyken C, Blümcke I, Fimmers R, Urbach H, Elger CE, Wiestler OD, Schramm J (2003) The spectrum of long-term epilepsy associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 44:822-830
14. Morris HH, Matkovic Z, Estes ML, Prayson RA, Comair YG, Turnbull J, Najm I, Kotagal P, Wyllie E (1998) Ganglioglioma and intractable epilepsy: clinical and neurophysiologic features and predictors of outcome after surgery. Epilepsia 39:307-313
15. Nelson JS, Bruner JM, Wiestler OD, Vandenberg SR (2000) Ganglioglioma and gangliocytoma. In: Cavenee WK (ed) Pathology and genetics of tumours of the nervous system. World Health Organization Classification of Tumours. IARC, Lyon, pp. 96-98
16. Piepmeier J, Christopher S, Spencer D, Byrne T, Kim J, Knisel JP, Lacy J, Tsukerman L, Makuch R (1996) Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 38:872-878
17. Shafit-Zagardo B, Davies P, Rockwood J, Kress Y, Lee SC (2000) Novel microtubule-associated protein-2 isoform is expressed early in human oligodendrocyte maturation. Glia 29: 233-245
18. Silver JM, Rawlings CE 3rd, Rossitch E Jr, Zeidman SM, Friedman AH (1991) Ganglioglioma: a clinical study with long-term follow-up. Surg Neurol 35:261-266
19. Suzuki SO, Kitai R, Llena J, Lee SC, Goldman JE, Shafit-Zagardo B (2002) MAP-2e, a novel MAP-2 isoform, is expressed in gliomas and delineates tumor architecture and patterns of infiltration. J Neuropathol Exp Neurol 61:403-412
20. Zentner J, Wolf HK, Ostertun B, Hufnagel A, Campos MG, Solymosi L, Schramm J (1994) Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients. J Neurol Neurosurg Psychiatry 57:1497-1502
21. Zentner J, Hufnagel A, Wolf HK, Ostertun B, Behrens E, Campos MG, Elger CE, Wiestler OD, Schramm J (1997) Surgical treatment of neoplasms associated with medically intractable epilepsy. Neurosurgery 41:378-386